Clinical Trial Update: An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating C-CAR031, a GPC3-targeted CAR T-cell therapy, in participants with advanced or metastatic squamous cell lung cancer; trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma

Drugs mentioned

• C-CAR031

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Squamous Cell Lung Cancer | Phase 1 | Status: RECRUITING